Denali Therapeutics Inc IPO Research Information

Denali Therapeutics Inc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Denali Therapeutics Inc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Denali Therapeutics Inc	DNLI - NASDAQ	$17.00-$19.00	$18.00	$21.55	13.88 million	12/8/2017
Underwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley
Co-Manager(s): Evercore ISI
Industry: Health Care
Filing(s): Filed 2017-11-13 Terms Added 2017-11-27 Terms Changed 2017-12-08 Final Prospectus 2017-12-08

Denali Therapeutics Inc Quote & Chart - Click for current quote - DNLI

About Denali Therapeutics Inc (adapted from Denali Therapeutics Inc prospectus):
Their goal is to discover and develop therapeutics to defeat degeneration.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DNLI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.